|
1.
|
AH AljubranA GriffinM PintilieM
BlacksteinOsteosarcoma in adolescents and adults: survival analysis
with and without lung metastasesAnn
Oncol2011361141200910.1093/annonc/mdn73119153114
|
|
2.
|
DA PotterJ GlennT KinsellaPatterns of
recurrence in patients with high-grade soft tissue sarcomasJ Clin
Oncol335336619853973646
|
|
3.
|
AG CassonJB PutnamG NatarajanEfficacy of
pulmonary metastasectomy for recurrent soft tissue sarcomaJ Surg
Oncol4714199110.1002/jso.29304701022023414
|
|
4.
|
M LaydanyiCR AntonescuP Dal CinCytogenetic
and Molecular Genetic Pathology of Soft Tissue TumorsEnzinger and
Weiss’s Soft Tissue TumorsSW WeissGoldblum JrMosbySt. Louis,
MO731022008
|
|
5.
|
EK AbdallaPW PistersMetastasectomy for
limited metastases from soft tissue sarcomaCurr Treat Options
Oncol3497505200210.1007/s11864-002-0069-112392639
|
|
6.
|
AG CassonJB PutnamG NatarajanFive-year
survival after pulmonary metastasectomy for adult soft tissue
sarcomaCancer6966266819921730117
|
|
7.
|
C ChaoM GoldbergSurgical treatment of
metastatic pulmonary soft-tissue sarcomaOncology (Williston
Park)148358412000discussion842844847
|
|
8.
|
TA HoranFF SantiagoLM AraujoThe benefit of
pulmonary metastectomy for bone and soft tissue sarcomasInt
Surg85185189200011324992
|
|
9.
|
LA LanzaJB PutnamRS BenjaminJA
RothResponse to chemotherapy does not predict survival after
resection of sarcomatous pulmonary metastasesAnn Thorac
Surg51219224199110.1016/0003-4975(91)90789-S1989534
|
|
10.
|
JD PredinaMM PucMDMR BergeySS SonnadJC
KucharczukA StaddonLR KaiserJB ShragerImproved survival after
pulmonary metastasectomy for soft tissue sarcomaJ Thorac
Oncol6913919201110.1097/JTO.0b013e3182106f5c21750417
|
|
11.
|
JB Putnam JrJA RothSurgical treatment for
pulmonary metastases from sarcomaHematol Oncol Clin North
Am986988719957490246
|
|
12.
|
RM QuirosWJ ScottSurgical treatment of
metastatic disease to the lungSemin
Oncol35134146200810.1053/j.seminoncol.2007.12.01018396199
|
|
13.
|
JA RothJB Putnam JrMN WesleySA
RosenbergDiffering determinants of prognosis following resection of
pulmonary metastases from osteogenic and soft tissue sarcoma
patientCancer5513611366198510.1002/1097-0142(19850315)55:6%3C1361::AID-CNCR2820550633%3E3.0.CO;2-F3855684
|
|
14.
|
CL SnyderDA SaltzmanKL FerrellRC
ThompsonAS LeonardA new approach to the resection of pulmonary
osteosarcoma metastases. Results of aggressive metastasectomyClin
Orthop Relat Res27024725319911884546
|
|
15.
|
DI SternbergJR SonettSurgical therapy of
lung metastasesSemin
Oncol34186196200710.1053/j.seminoncol.2007.03.00417560980
|
|
16.
|
EH StephensSH BlackmonAM CorreaProgression
after chemotherapy is a novel predictor of poor outcomes after
pulmonary metastasectomy in sarcoma patientsJ Am Coll
Surg212821826201110.1016/j.jamcollsurg.2011.01.00721435923
|
|
17.
|
DJ SugarbakerJP GarciaWG
RichardsExtrapleural pneumonectomy in the multimodality therapy of
malignant pleural mesothelioma. Results in 120 consecutive
patientsAnn Surg2242882941996discussion294296
|
|
18.
|
AN van GeelU PastorinoKW JauchSurgical
treatment of lung metastases: The European Organization for
Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group
study of 255 patientsCancer776756821996
|
|
19.
|
R DaylamiA AmiriB GoldsmithC TroppmannPD
SchneiderVP KhatriInferior vena cava leiomyosarcoma: is
reconstruction necessary after resection?J Am Coll
Surg210185190201010.1016/j.jamcollsurg.2009.10.01020113938
|
|
20.
|
RF LohmanAS NabawiGP ReeceSoft tissue
sarcoma of the upper extremity: a 5-year experience at two
institutions emphasizing the role of soft tissue flap
reconstructionCancer9422562264200212001125
|
|
21.
|
RC MarcoveDS ShethJ HealeyLimb-sparing
surgery for extremity sarcomaCancer
Invest12497504199410.3109/073579094090214107922707
|
|
22.
|
AA ValleWG KraybillManagement of soft
tissue sarcomas of the extremity in adultsJ Surg
Oncol63271279199610.1002/(SICI)1096-9098(199612)63:4%3C271::AID-JSO11%3E3.0.CO;2-68982374
|
|
23.
|
WC WilliardC CollinES CasperThe changing
role of amputation for soft tissue sarcoma of the extremity in
adultsSurg Gynecol Obstet17538939619921440165
|
|
24.
|
A PollackGK ZagarsMS GoswitzPreoperative
vs. postoperative radiotherapy in the treatment of soft tissue
sarcomas: a matter of presentationInt J Radiat Oncol Biol
Phys42563572199810.1016/S0360-3016(98)00277-69806516
|
|
25.
|
RA SchmidtEU Conrad IIIC CollinsA
RabinovichA FinneyMeasurement and prediction of the short-term
response of soft tissue sarcomas to
chemotherapyCancer7225932601199310.1002/1097-0142(19931101)72:9%3C2593::AID-CNCR2820720914%3E3.0.CO;2-D8402481
|
|
26.
|
GS SchoenfeldCG MorrisMT ScarboroughRA
ZloteckiAdjuvant radiotherapy in the management of soft tissue
sarcoma involving the distal extremitiesAm J Clin
Oncol296265200610.1097/01.coc.0000197660.23734.2416462505
|
|
27.
|
WJ TempleCL TempleK ArthurProspective
cohort study of neoadjuvant treatment in conservative surgery of
soft tissue sarcomasAnn Surg
Oncol4586590199710.1007/BF023055419367026
|
|
28.
|
JC YangAE ChangAR BakerRandomized
prospective study of the benefit of adjuvant radiation therapy in
the treatment of soft tissue sarcomas of the extremityJ Clin
Oncol1619720319989440743
|
|
29.
|
F EilberAE GuilianoJF HuthIntravenous
versus intra-arterial Adriamycin, 2800 radiation and surgical
excision for extremity soft tissue sarcomas. A randomized
prospective trialASCO Proceedings93091990
|
|
30.
|
RN TaubKH AntmanSoft tissue tumorsCurrent
Therapy in CancerJF FoleyJM VoseJO ArmitageWB Saunders
CompanyPhiladelphia, PA2592701999
|
|
31.
|
G RosenCA ForscherFR EilbergOsteogenic
sarcomaCancer TreatmentCM HaskellWB Saunders CompanyPhiladelphia,
PA124412582001
|
|
32.
|
K AntmanJ CrowleySP BalcerzakAn intergroup
phase III randomized study of doxorubicin and dacarbazine with or
without ifosfamide and mesna in advanced soft tissue and bone
sarcomasJ Clin Oncol111276128519938315425
|
|
33.
|
EC BordenDA AmatoC RosenbaumRandomized
comparison of three adriamycin regimens for metastatic soft tissue
sarcomasJ Clin Oncol584085019873585441
|
|
34.
|
XG Del MuroAL PousaJM BuesaTemozolamide as
a 6-week continuous oral schedule in advance soft tissue sarcoma
(STS): a phase II trial of the Spanish Group for Research on
Sarcomas (GEIS)ASCO proceedings (abstract 1412)2001
|
|
35.
|
JA GottliebRS BenjaminLH BakerRole of DTIC
(NSC-45388) in the chemotherapy of sarcomasCancer Treat
Rep601992031976769974
|
|
36.
|
G RosenS ChawlaS HamburgLoweqbraunPhase II
study of high dose continuous infusion dimethyl triazeno
carboxamide (DTIC) in metastatic leiomyosarcomaASCO proceedings
(abstract 1210)1990
|
|
37.
|
A SantoroT TurszH MouridsenDoxorubicin
versus CYVADIC versus doxorubicin plus ifosfamide in first-line
treatment of advanced soft tissue sarcomas: a randomized study of
the European Organization for Research and Treatment of Cancer Soft
Tissue and Bone Sarcoma GroupJ Clin Oncol13153715451995
|
|
38.
|
M ZalupskiB MetchS BalcerzakPhase III
comparison of doxorubicin and dacarbazine given by bolus versus
infusion in patients with soft-tissue sarcomas: a Southwest
Oncology Group studyJ Natl Cancer
Inst83926932199110.1093/jnci/83.13.9262067035
|
|
39.
|
ML HensleyR MakiE VenkatramanGemcitabine
and docetaxel in patients with unresectable leiomyosarcoma: results
of a phase II trialJ Clin
Oncol2028242831200210.1200/JCO.2002.11.05012065559
|
|
40.
|
CD BlankeGD DemetriM von MehrenLong-term
results from a randomized phase II trial of standard- versus
higher-dose imatinib mesylate for patients with unresectable or
metastatic gastrointestinal stromal tumors expressing KITJ Clin
Oncol26620625200810.1200/JCO.2007.13.440318235121
|
|
41.
|
D GarbayA Le CesneN PenelC ChevreauP
Marec-BerardJY BlayM DebledN IsambertA ThyssE BompasChemotherapy in
patients with desmoid tumors: a study from the French Sarcoma Group
(FSG)Ann Oncol23182186201210.1093/annonc/mdr05121444357
|
|
42.
|
MM GounderRA LefkowitzML KeohanDR D’AdamoM
HameedCR AntonescuS SingerK StoutL AhnRG MakiActivity of Sorafenib
against desmoid tumor/deep fibromatosisClin Cancer
Res1517:40824090201110.1158/1078-0432.CCR-10-332221447727
|
|
43.
|
G KnechtelH StoegerJ SzkanderaK DorrA
BehamH SamoniggDesmoid tumor treated with polychemotherapy followed
by imatinib: a case report and review of the literatureCase Rep
Oncol3287293201010.1159/00031887321347195
|
|
44.
|
No authors listed:Adjuvant chemotherapy
for localised resectable soft-tissue sarcoma of adults:
meta-analysis of individual data. Sarcoma Meta-analysis
CollaborationLancet35016471654199710.1016/S0140-6736(97)08165-89400508
|
|
45.
|
S FrustaciF GherlinzoniA De PaoliAdjuvant
chemotherapy for adult soft tissue sarcomas of the extremities and
girdles: results of the Italian randomized cooperative trialJ Clin
Oncol1912381247200111230464
|
|
46.
|
JJ LewisD LeungJM WoodruffRetroperitoneal
soft-tissue sarcoma: analysis of 500 patients treated and followed
at a single institutionAnn
Surg228355365199810.1097/00000658-199809000-000089742918
|
|
47.
|
K O’ByrneWP StewardThe role of adjuvant
chemotherapy in the treatment of adult soft tissue sarcomasCrit Rev
Oncol Hematol272212271998
|
|
48.
|
KE AllenGJ WeissResistance may not be
futile: microRNA biomarkers for chemoresistance and potential
therapeuticsMol Cancer
Ther931263136201010.1158/1535-7163.MCT-10-039720940321
|
|
49.
|
TO NielsenRB WestTranslating gene
expression into clinical care: sarcomas as a paradigmJ Clin
Oncol2817961805201010.1200/JCO.2009.26.191720194847
|
|
50.
|
GJ WeissA AlarconM HalepotaRJ PennyDD Von
HoffMolecular characterization of interdigitating dendritic cell
sarcomaRare Tumors2e50201010.4081/rt.2010.e5021139965
|
|
51.
|
RF RiedelTargeted agents for sarcoma: is
individualized therapy possible in such a diverse tumor type?Semin
Oncol38Suppl
3S30S42201110.1053/j.seminoncol.2011.09.00322055970
|
|
52.
|
MG FuryCR AntonescuKJ Van ZeeA 14-year
retrospective review of angiosarcoma: clinical characteristics,
prognostic factors and treatment outcomes with surgery and
chemotherapyCancer J11241247200516053668
|
|
53.
|
E PalassiniS StachiottiT NegriSunitinib
malate (SM) in alveolar soft part sarcoma (ASPS)J Clin
Oncol28Suppl15s2010
|
|
54.
|
L BoudouM BaconnierJY BlayC
Lombard-BohasPA CassierTrabectedin for the management of
soft-tissue sarcomaAnticancer
Ther9727737200910.1586/era.09.2819496709
|
|
55.
|
U BassoA BrunelloA BertuzziA
SantoroSorafenib is active on lung metastases from synovial
sarcomaAnn Oncol20386387200910.1093/annonc/mdn68519211500
|
|
56.
|
RG MakiDR D’AdamoML KeohanPhase II study
of sorafenib in patients with metastatic or recurrent sarcomasJ
Clin Oncol2731333140200910.1200/JCO.2008.20.449519451436
|
|
57.
|
CL PengW GuoT JiT RenY YangDS LiHY QuX LiS
TangTQ YanXD TangSorafenib induces growth inhibition and apoptosis
in human synovial sarcoma cells via inhibiting the RAF/MEK/ERK
signaling pathwayCancer Biol
Ther817291736200910.4161/cbt.8.18.920819633425
|
|
58.
|
T ShitaraA ShimadaR HanadaT MatsunagaK
KawaH MugishimaT SugimotoJ MimayaA ManabeM TsurusawaY
TsuchidaIrinotecan for children with relapsed solid tumorsPediatr
Hematol Oncol23103110200610.1080/0888001050045715216651238
|
|
59.
|
GW HergetM UhlOG OpitzThe many faces of
chondrosarcoma of bone, own cases and review of the literature with
an emphasis on radiology, pathology and treatmentActa Chir Orthop
Traumatol Cech78501509201122217402
|
|
60.
|
AP Dei TosAJ WagnerP ModenaA ComandoneS
LeyvrazEpithelioid soft tissue tumorsSemin
Oncol36347357200919664495
|
|
61.
|
JJ BisslerFX McCormackLR YoungSirolimus
for angiomyolipoma in tuberous sclerosis complex or
lymphangioleiomyomatosisN Engl J
Med358140151200810.1056/NEJMoa06356418184959
|
|
62.
|
DM DaviesSR JohnsonAE
TattersfieldSirolimus therapy in tuberous sclerosis or sporadic
lymphangioleiomyomatosisN Engl J
Med358200203200810.1056/NEJMc07250018184971
|
|
63.
|
C TailléMP DebrayB CrestaniSirolimus
treatment for pulmonary lymphangioleiomyomatosisAnn Intern
Med146687688200717470843
|
|
64.
|
AJ WagnerI Malinowska-KolodziejJA
MorganClinical activity of mTOR inhibition with sirolimus in
malignant perivascular epithelioid cell tumors: targeting the
pathogenic activation of mTORC1 in tumorsJ Clin
Oncol28835201010.1200/JCO.2009.25.298120048174
|
|
65.
|
BD LooyengaI CherniJP MackeiganGJ
WeissTailoring tyrosine kinase inhibitors to fit the lung cancer
genomeTransl Oncol45970201110.1593/tlo.1024121461169
|
|
66.
|
DR D’AdamoIntegrating novel therapies into
the treatment of sarcoma: A multidisciplinary approach -
introductionSemin Oncol38Suppl 3S1S2201122055967
|
|
67.
|
EG DemiccoAJ LazarClinicopathologic
considerations: how can we fine tune our approach to sarcoma?Semin
Oncol38Suppl 3S3S18201110.1053/j.seminoncol.2011.09.00122055969
|
|
68.
|
SP ChawlaAW TolcherAP StaddonSurvival
results with AP23573, a novel mTOR inhibitor, in patients (pts)
with advanced soft tissue or bone sarcomas: Update of phase II
trialJ Clin Oncol25Suppl18S2007
|
|
69.
|
CM HartfordAA DesaiL JanischA phase I
trial to determine the safety, tolerability, and maximum tolerated
dose of deforolimus in patients with advanced malignanciesClin
Cancer Res1514281434200910.1158/1078-0432.CCR-08-207619228743
|
|
70.
|
MM MitaCD BrittenE PoplinDeforolimus trial
106 - a phase I trial evaluating 7 regimens of oral deforolimus
(AP23573, MK-8669)J Clin Oncol2635092008
|
|
71.
|
MM MitaAC MitaQS ChuPhase I trial of the
novel mammalian target of rapamycin inhibitor deforolimus (AP23573;
MK-8669) administered intravenously daily for 5 days every 2 weeks
to patients with advanced malignanciesJ Clin
Oncol26361367200810.1200/JCO.2007.12.0345
|
|
72.
|
SP ChalwaJ BlayRay-CoquardResults of the
phase III, placebo-controlled trial (SUCCEED) evaluating the mTOR
inhibitor ridaforolimus (R) as maintenance therapy in advanced
sarcoma patients (pts) following clinical benefit from prior
standard cytotoxic chemotherapy (CT)J Clin Oncol29abstract
100052011
|
|
73.
|
CF CollinC FriedrichJ GodboldPrognostic
factors for local recurrence and survival in patients with
localized extremity soft-tissue sarcomaSemin Surg
Oncol43037198810.1002/ssu.29800401083353622
|
|
74.
|
M FanucchiUpdate of the management of
connective tissue malignanciesSemin Oncol31Suppl
41619200410.1053/j.seminoncol.2004.02.010
|
|
75.
|
H SolimanA FerrariD ThomasSarcoma in the
young adult population: an international viewSemin
Oncol36227236200910.1053/j.seminoncol.2009.03.00619460580
|
|
76.
|
SR PatelGK ZagarsPWT PistersThe follow-up
of adult soft-tissue sarcomasSemin
Oncol30413416200310.1016/S0093-7754(03)00101-512870143
|
